Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedGastric cancer was added to the list of conditions for the study, broadening the potential population the page pertains to. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the site revision banner updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed, indicating a version update that does not change study details or how the page is used.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, replacing the previous revision entry.SummaryDifference0.0%

- Check69 days agoChange DetectedA new consolidated Locations section lists participating sites across California, Colorado, Kentucky, Michigan, New York, Pennsylvania, South Dakota, Texas, and Utah, replacing the prior per-state headings. The footer revision note also updates from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check90 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing v3.2.0. This update is limited to a software/version change and does not alter study details or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check98 days agoChange DetectedRemoved a general government funding status notice from the page; this banner is administrative and does not affect trial details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.